🇺🇸 FDA
Pipeline program

Atomoxetine Aurobindo 40 mg hard capsules, Microcrystalline cellulose gelatin capsule

116130

Phase 3 small_molecule active

Quick answer

Atomoxetine Aurobindo 40 mg hard capsules, Microcrystalline cellulose gelatin capsule for Parkinson's disease is a Phase 3 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Parkinson's disease
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials